Document is current
Any future updates will be listed below
-
Authors
Gelardi, Edoardo L. M.
Caprioglio, Diego
Colombo, Giorgia
Del Grosso, Erika
Mazzoletti, Daniele http://orcid.org/0000-0002-0711-8269
Mattoteia, Daiana
Salamone, Stefano
Ferraris, Davide M. http://orcid.org/0000-0001-5112-9910
Aronica, Eleonora
Nato, Giulia
Buffo, Annalisa http://orcid.org/0000-0001-7637-0006
Rizzi, Menico http://orcid.org/0000-0002-7930-399X
Magrassi, Lorenzo http://orcid.org/0000-0002-8308-2720
Minassi, Alberto http://orcid.org/0000-0002-3640-2912
Garavaglia, Silvia http://orcid.org/0000-0001-8494-1729
-
Funding
Funding for this research was provided by:
Fondazione IRCCS Policlinico San Matteo
Università degli Studi del Piemonte Orientale (FAR_2016, FAR_2019)
Roche
- License Information
-
More Information
Article History
Received: 27 May 2021
Accepted: 9 August 2022
First Online: 1 September 2022
Competing interests
: The authors declare the following competing interest: the work reported in these papers led to a patent name: “PROBE DIRECTED TO ENZYME ALDH1A3 AND USE THEREOF IN THE DIAGNOSIS OF GLIOBLASTOMA”; number: PCT/IB2022/053216 (6 April 2022); geographical region: International Application (PCT); applicants: University of Piemonte Orientale 90%; University of Pavia 10%; inventors: S.G., A.M., M.R., E.L.M.G., D.C., G.C., L.M.
